Mehdi Norouzi Selected Research

Biomarkers (Surrogate Marker)

11/2023	Possible ameliorative role of Spirulina platensis on coagulation factors, lymphocytopenia, and malnutrition in ICU patients with COVID-19.
9/2023	Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review.
1/2022	Identifying Potential New Gene Expression-Based Biomarkers in the Peripheral Blood Mononuclear Cells of Hepatitis B-Related Hepatocellular Carcinoma.
6/2021	Comprehensive high-throughput meta-analysis of differentially expressed microRNAs in transcriptomic datasets reveals significant disruption of MAPK/JNK signal transduction pathway in Adult T-cell leukemia/lymphoma.
12/2019	An insight to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) pathogenesis; evidence from high-throughput data integration and meta-analysis.
1/2016	Evaluation of Non-Viral Surrogate Markers as Predictive Indicators for Monitoring Progression of Human Immunodeficiency Virus Infection: An Eight-Year Analysis in a Regional Center.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mehdi Norouzi Research Topics

Disease

10	Infections 05/2024 - 01/2013
6	Hepatitis B 10/2022 - 01/2014
5	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 09/2023 - 01/2017
4	Neoplasms (Cancer) 10/2023 - 01/2017
4	Chronic Hepatitis B 01/2022 - 01/2013
3	COVID-19 11/2023 - 07/2021
2	Fibrosis (Cirrhosis) 10/2022 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2017
1	Virus Diseases (Viral Diseases) 01/2024
1	Lymphopenia (Lymphocytopenia) 11/2023
1	Malnutrition (Nutritional Deficiencies) 11/2023
1	Papillomavirus Infections 10/2023
1	Lymphoma (Lymphomas) 09/2023
1	Cough 01/2022
1	Fever (Fevers) 01/2022
1	Headache (Headaches) 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Dyspnea (Shortness of Breath) 01/2022
1	Coinfection 11/2020
1	Communicable Diseases (Infectious Diseases) 05/2020
1	Necrosis 01/2020
1	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 12/2019
1	Spinal Cord Diseases 12/2019
1	T-Cell Leukemia (Leukemia, T Cell) 12/2019
1	Keratitis 05/2019
1	Autistic Disorder (Autism) 01/2019
1	Autism Spectrum Disorder 01/2019
1	Disease Progression 01/2016
1	Hepatitis 09/2015
1	Cryptogenic Cirrhosis 03/2014
1	Liver Diseases (Liver Disease) 03/2014
1	Viremia 01/2014
1	Persistent Infection 07/2013

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2016
4	DNA (Deoxyribonucleic Acid)IBA 08/2021 - 03/2014
3	Antiviral Agents (Antivirals)IBA 01/2024 - 06/2016
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019 - 01/2014
3	Membrane Proteins (Integral Membrane Proteins)IBA 06/2016 - 07/2013
2	Messenger RNA (mRNA)IBA 05/2024 - 04/2017
2	Proteins (Proteins, Gene)FDA Link 05/2024 - 04/2017
2	VaccinesIBA 10/2023 - 10/2021
2	MicroRNAs (MicroRNA)IBA 10/2022 - 06/2021
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2017 - 01/2017
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 04/2017 - 01/2017
2	Lamivudine (Epivir)FDA Link 06/2016 - 09/2015
2	Surface Antigens (Surface Antigen)IBA 03/2014 - 01/2014
1	Blood Coagulation Factors (Coagulation Factor)IBA 11/2023
1	HTLV-I AntibodiesIBA 06/2023
1	human MIRN146 microRNAIBA 10/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	Ammonium Chloride (Sal Ammoniac)FDA Link 07/2021
1	Quaternary Ammonium CompoundsIBA 07/2021
1	human MIRN186 microRNAIBA 06/2021
1	human MIrn181 microRNAIBA 06/2021
1	TransferasesIBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	Alkaline PhosphataseIBA 01/2020
1	InterleukinsIBA 12/2019
1	InterferonsIBA 12/2019
1	Viral RNAIBA 12/2019
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2019
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 04/2017
1	AntibodiesIBA 01/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2016
1	lipoarabinomannan (LAM)IBA 06/2016
1	adefovir dipivoxil (Hepsera)FDA Link 06/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Immunologic Factors (Immunomodulators)IBA 01/2013
1	NucleotidesIBA 01/2013

Therapy/Procedure

2	Therapeutics 09/2023 - 06/2016
1	Stem Cell Transplantation 09/2023
1	Liver Transplantation 10/2022
1	Renal Dialysis (Hemodialysis) 11/2020
1	Transplantation 11/2020
1	Contact Lenses 05/2019